HKUST Commences Preparations for New Medical School
Inaugural Cohort in 2028, Cultivating Clinically Excellent and Technology-Savvy Doctors of the Future…
GBS Malta Celebrates Landmark Inaugural Graduation
ST JULIAN'S, Malta, Nov. 19, 2025 /PRNewswire/ -- GBS Malta, part of…
Comprehensive Healthcare Takes Next Step Toward Expanding Access to Behavioral Healthcare in Central Washington
YAKIMA, Wash., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Comprehensive Healthcare today announced…
GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed…
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase…
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinsons disease
Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at…
Ten athlete ambassadors engaged in preventing competition manipulation announced
10 September 2025 – Ten athletes from every continent and 10 different…
Mohamed bin Zayed University of Artificial Intelligence begins new academic year with largest-ever cohort of 400+ students
ABU DHABI,UAE, Aug. 16, 2025 /PRNewswire/ -- Mohamed bin Zayed University of…
Alamar Biosciences and the German Center for Neurodegenerative Diseases (DZNE) partner for Landmark Proteomic Profiling study in the Rhineland Study Cohort
NULISAseqâ„¢ CNS Disease Panel 120 and Inflammation Panel 250 to Power Biomarker…
SPJIMR’s PGDM Class of 2027 celebrates leadership, diversity, and purpose
New cohort embarks on a transformative journey in management and leadership MUMBAI,…